Health Care & Life Sciences » Biotechnology | ProMIS Neurosciences Inc.

ProMIS Neurosciences Inc.

ProMIS Neurosciences Inc.
Stock Exchange Other OTC
EPS
$0.03
Market Cap
$42.35 M
Shares Outstanding
246.13 M
Public Float
-
ProMIS Neurosciences Inc.
Stock Exchange Toronto Stock Exchange Prices
EPS
CAD0.05
Market Cap
CAD52.28 M
Shares Outstanding
181.72 M
Public Float
153.45 M

Profile

Address
1920 Yonge Street
Toronto Ontario M4S 3E2
Canada
Employees -
Website http://www.promisneurosciences.com
Updated 07/08/2019
ProMIS Neurosciences, Inc. operates as a development stage biotech company. It discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment of neurodegenerative diseases, in particular Alzheimer's disease and amyotrophic lateral sclerosis. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.

Financials

View All
Created with Highcharts 5.0.14ProMIS Neurosciences Inc.Net Income. Fiscal year is January-December. All values CAD Thousands.2 2302 2302 8552 8552 1212 1213 4553 4556 0206 02010 16710 16720132014201520162017201802.5k5k7.5k10k12.5k
Created with Highcharts 5.0.14ProMIS Neurosciences Inc.Sales/Revenue. Fiscal year is January-December. All values CAD Thousands.494934334319192299002013201420152016201720180100200300400

Eugene Williams
Executive Chairman
Elliot Goldstein
President, Chief Executive Officer & Director